: Leading up to its acquisition, the company reported a Q2 2024 revenue of $2.2 million but sustained a net loss of $25.7 million for the same period. Investment Outlook
: Under the terms of the merger agreement, all outstanding shares of ASXC were acquired for $0.35 per share in cash . trxc stock buy or sell
: The symbol transitioned from TRXC to ASXC as part of this corporate shift. : Leading up to its acquisition, the company
AI responses may include mistakes. For financial advice, consult a professional. Learn more AI responses may include mistakes
Since the company is now , it is not possible to buy or sell shares on public markets.
The ticker is no longer active for trading. TransEnterix, the company originally associated with that symbol, rebranded as Asensus Surgical and changed its ticker to ASXC in March 2021. Subsequently, Asensus Surgical was acquired by KARL STORZ and its stock was officially delisted in August 2024. Stock Status and Delisting